These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20437542)

  • 21. Exploring the Spectrum of Visual Illusions and Other Minor Hallucinations in Patients with Parkinson's Disease in Lithuania.
    Jucevičiūtė N; Balnytė R; Laucius O
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674252
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.
    Pacchetti C; Manni R; Zangaglia R; Mancini F; Marchioni E; Tassorelli C; Terzaghi M; Ossola M; Martignoni E; Moglia A; Nappi G
    Mov Disord; 2005 Nov; 20(11):1439-48. PubMed ID: 16028215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence, associated factors and phenomenology of psychosis in patients with Parkinson's disease].
    Rodríguez-Violante M; Velázquez-Osuna S; Cervantes-Arriaga A; Corona-Vázquez T; de la Fuente-Sandoval C
    Gac Med Mex; 2015; 151(2):169-75. PubMed ID: 25946527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Implications of the National Institute of Neurological Disorders and Stroke Criteria for Diagnosing Psychosis in Parkinson's Disease.
    Gordon PC; Kauark RB; Costa CD; de Oliveira MO; Godinho FL; Rocha MS
    J Neuropsychiatry Clin Neurosci; 2016; 28(1):26-31. PubMed ID: 26449268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of hallucinations and delusions in Parkinson's disease.
    Holroyd S; Currie L; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):734-8. PubMed ID: 11385005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive correlates of hallucinations and delusions in Parkinson's disease.
    Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; McDonald WM; Goldstein FC
    J Neurol Sci; 2014 Dec; 347(1-2):316-21. PubMed ID: 25466695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of Cannabis on hallucinations in Parkinson's disease patients.
    Cravanas B; Frei K
    J Neurol Sci; 2020 Dec; 419():117206. PubMed ID: 33161300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does an association between cigarette smoking and Parkinson's Disease-related psychosis exist? Insights from a large non-demented cohort.
    Terravecchia C; Mostile G; Rascunà C; Arabia G; Barone P; Marconi R; Morgante L; Quattrone A; Nicoletti A; Zappia M
    J Neurol Sci; 2021 Aug; 427():117509. PubMed ID: 34082149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson's Disease.
    Pachi I; Papadopoulos V; Koros C; Simitsi AM; Bougea A; Bozi M; Papagiannakis N; Soldatos RF; Kolovou D; Pantes G; Scarmeas N; Paraskevas G; Voumvourakis K; Papageorgiou SG; Kollias K; Stefanis N; Stefanis L
    J Parkinsons Dis; 2023; 13(7):1185-1197. PubMed ID: 37840503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psychosis in Parkinson's disease].
    Rongve A; Auning E; Ehrt U; Arsland D
    Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study.
    Sawada H; Oeda T; Umemura A; Tomita S; Hayashi R; Kohsaka M; Yamamoto K; Sudoh S; Sugiyama H
    PLoS One; 2014; 9(1):e85886. PubMed ID: 24497930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence and characteristics of hallucinations, delusions and minor phenomena in a non-demented population sample aged 60 years and over.
    Soulas T; Cleret de Langavant L; Monod V; Fénelon G
    Int J Geriatr Psychiatry; 2016 Dec; 31(12):1322-1328. PubMed ID: 26876683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments.
    Rojas M; Chávez-Castillo M; Duran P; Ortega Á; Bautista-Sandoval MJ; Salazar J; Riaño-Garzón M; Chacín M; Medina-Ortiz O; Palmar J; Cudris-Torres L; Bermúdez V
    Curr Pharm Des; 2022; 28(33):2725-2741. PubMed ID: 36321314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Victor Parant (1848-1924) and the first report of psychosis in the course of Parkinson's disease with dementia.
    Fénelon G; Parant J; Cleret de Langavant L
    Rev Neurol (Paris); 2021 Dec; 177(10):1221-1227. PubMed ID: 34247848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosis in Parkinson's Disease.
    Ffytche DH; Aarsland D
    Int Rev Neurobiol; 2017; 133():585-622. PubMed ID: 28802934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hallucinations and other psychotic experiences across diagnoses: A comparison of phenomenological features.
    Schutte MJL; Linszen MMJ; Marschall TM; Ffytche DH; Koops S; van Dellen E; Heringa SM; Slooter AJC; Teunisse R; van den Heuvel OA; Lemstra AW; Foncke EMJ; Slotema CW; de Jong J; Rossell SL; Sommer IEC
    Psychiatry Res; 2020 Oct; 292():113314. PubMed ID: 32731082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.
    Pagonabarraga J; Martinez-Horta S; Fernández de Bobadilla R; Pérez J; Ribosa-Nogué R; Marín J; Pascual-Sedano B; García C; Gironell A; Kulisevsky J
    Mov Disord; 2016 Jan; 31(1):45-52. PubMed ID: 26408291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.
    Aarsland D; Larsen JP; Cummins JL; Laake K
    Arch Neurol; 1999 May; 56(5):595-601. PubMed ID: 10328255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric features of Parkinson's disease in the era prior to the use of dopaminergic therapies.
    Zhang C; Reeves S; David AS; Costello H; Rogers J
    Cogn Neuropsychiatry; 2023 Jul; 28(4):243-252. PubMed ID: 37170593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychotic symptoms in Parkinson's disease].
    Fénelon G
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4 Spec No 1():S17-24. PubMed ID: 23631044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.